← All Sponsors
SPONSOR

Essen Biotech

Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: SarcomaSarcoma, KaposiSarcoma, EwingSarcoma,Soft TissueSarcoma of Bone and Connective TissueSarcoma, SynovialSarcoma MetastaticSarcomas, GerminoblasticSarcoma of BoneAutoimmune Diseases
NCT07066982 Phase 1, Phase 2
Recruiting

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

Sarcoma
China View Trial →
NCT06428188 Phase 1, Phase 2
Recruiting

Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Autoimmune Diseases
China View Trial →
NCT07410494 Phase 1, Phase 2
Recruiting

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer
China View Trial →
NCT06532799 Phase 1, Phase 2
Recruiting

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

Stomach Cancer
China View Trial →